Your browser doesn't support javascript.
loading
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.
Ludwig, Heinz; Boccadoro, Mario; Moreau, Philippe; San-Miguel, Jesus; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Facon, Thierry; Driessen, Christoph; Hajek, Roman; Dimopoulos, Melitios A; Gay, Francesca; Avet-Loiseau, Hervé; Terpos, Evangelos; Zojer, Niklas; Mohty, Mohamad; Mateos, Maria-Victoria; Einsele, Hermann; Delforge, Michel; Caers, Jo; Weisel, Katja; Jackson, Graham; Garderet, Laurent; Engelhardt, Monika; van de Donk, Niels; Leleu, Xavier; Goldschmidt, Hartmut; Beksac, Meral; Nijhof, Inger; Abildgaard, Niels; Bringhen, Sara; Sonneveld, Pieter.
Afiliación
  • Ludwig H; Wilhelminen Cancer Research Institute, c/o 1st Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria. heinz.ludwig@extern.gesundheitsverbund.at.
  • Boccadoro M; Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Moreau P; Service hematologie et thérapie cellulaire, PRC. cic 1402 Inserm, CHU poitiers, Poitiers, France.
  • San-Miguel J; CIMA, IDISNA, CIBERONC, Clínica Universidad de Navarra, Pamplona, Spain.
  • Cavo M; Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
  • Pawlyn C; The Institute of Cancer Research, London, UK.
  • Zweegman S; Department of Hematology, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
  • Facon T; Hôpital Claude Huriez, Lille University Hospital, Lille, France.
  • Driessen C; Department of Medical Oncology and Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
  • Hajek R; Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Dimopoulos MA; Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Gay F; Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Avet-Loiseau H; Unité de Génomique du Myélome, University of Toulouse, Toulouse, France.
  • Terpos E; Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
  • Zojer N; 1st Department of Medicine, Center for Hematology, Oncology, and Palliatic Care, Clinic Ottakring, Vienna, Austria.
  • Mohty M; Department of Clinical Hematology and Cellular Therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France.
  • Mateos MV; IBSAL, Cancer Research Center, University Hospital of Salamanca, Salamanca, Spain.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Delforge M; Department of Hematology, UZ Leuven, Leuven, Belgium.
  • Caers J; Department of Clinical Hematology, CHU of Liège, Liège, Belgium.
  • Weisel K; II. Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Jackson G; NCCC, Newcastle upon Tyne Hospitals Trust, Newcastle upon Tyne, UK.
  • Garderet L; INSERM, UMR_S 938, Centre de Recherche Saint-Antoine-Team Proliferation and Differentiation of Stem Cells, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Service d'Hématologie, Sorbonne Université, Paris, France.
  • Engelhardt M; Interdisciplinary Tumor Center, Faculty of Freiburg, University of Freiburg, Freiburg, Germany.
  • van de Donk N; Department of Hematology, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
  • Leleu X; Poitiers University Hospital, Poitiers, France.
  • Goldschmidt H; Internal Medicine V and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.
  • Nijhof I; Department of Hematology, Amsterdam UMC, VU University, Amsterdam, The Netherlands.
  • Abildgaard N; Department of Hematology, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
  • Bringhen S; Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.
  • Sonneveld P; Erasmus MC Cancer Institute, Erasmus University of Rotterdam, Rotterdam, The Netherlands.
Leukemia ; 35(1): 31-44, 2021 01.
Article en En | MEDLINE | ID: mdl-32814840
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Vacunas / Control de Enfermedades Transmisibles / Enfermedades Transmisibles / Vacunación / Guías de Práctica Clínica como Asunto / Mieloma Múltiple Tipo de estudio: Guideline / Systematic_reviews Aspecto: Determinantes_sociais_saude Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Vacunas / Control de Enfermedades Transmisibles / Enfermedades Transmisibles / Vacunación / Guías de Práctica Clínica como Asunto / Mieloma Múltiple Tipo de estudio: Guideline / Systematic_reviews Aspecto: Determinantes_sociais_saude Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Austria